ID | Term | Allele | Alleles | Background | Color Key |
---|
MP:0005465 | abnormal T-helper 1 physiology |
Cebpbtm1Aki |
Cebpbtm1Aki/Cebpbtm1Aki | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0005465 | abnormal T-helper 1 physiology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0005466 | abnormal T-helper 2 physiology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0005666 | abnormal adipose tissue physiology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002896 | abnormal bone mineralization |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0002896 | abnormal bone mineralization |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0008271 | abnormal bone ossification |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0008271 | abnormal bone ossification |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0010867 | abnormal bone trabecula morphology |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0000662 | abnormal branching of the mammary ductal tree |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | either: 129S1/SvImJ-Cebpb or (involves: 129S1/SvImJ * C57BL/6) | color key |
MP:0000662 | abnormal branching of the mammary ductal tree |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0002971 | abnormal brown adipose tissue morphology |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0005076 | abnormal cell differentiation |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0002421 | abnormal cell-mediated immunity |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0001553 | abnormal circulating free fatty acids level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0005319 | abnormal enzyme/ coenzyme level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0003383 | abnormal gluconeogenesis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0003383 | abnormal gluconeogenesis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002078 | abnormal glucose homeostasis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0002078 | abnormal glucose homeostasis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002123 | abnormal hematopoiesis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0001800 | abnormal humoral immune response |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002419 | abnormal innate immunity |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0001882 | abnormal lactation |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | either: 129S1/SvImJ-Cebpb or (involves: 129S1/SvImJ * C57BL/6) | color key |
MP:0002118 | abnormal lipid homeostasis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002344 | abnormal lymph node B cell domain morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002347 | abnormal lymph node T cell domain morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002343 | abnormal lymph node cortex morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002348 | abnormal lymph node medulla morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0011224 | abnormal lymph node medullary cord morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002346 | abnormal lymph node secondary follicle morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002451 | abnormal macrophage physiology |
Cebpbtm1Aki |
Cebpbtm1Aki/Cebpbtm1Aki | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0002451 | abnormal macrophage physiology |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0002451 | abnormal macrophage physiology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0000628 | abnormal mammary gland development |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | either: 129S1/SvImJ-Cebpb or (involves: 129S1/SvImJ * C57BL/6) | color key |
MP:0000628 | abnormal mammary gland development |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0009503 | abnormal mammary gland duct morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0001881 | abnormal mammary gland physiology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0002377 | abnormal mucosa-associated lymphoid tissue morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0004130 | abnormal muscle cell glucose uptake |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0000750 | abnormal muscle regeneration |
Cebpbtm3Nerl |
Cebpbtm3Nerl/Cebpbtm3Nerl | either: B6.129P2-Cebpb or (involves: 129P2/OlaHsd * C57BL/6) | color key |
MP:0008395 | abnormal osteoblast differentiation |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0005006 | abnormal osteoblast physiology |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0005006 | abnormal osteoblast physiology |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0008396 | abnormal osteoclast differentiation |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0008396 | abnormal osteoclast differentiation |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0004982 | abnormal osteoclast morphology |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0004982 | abnormal osteoclast morphology |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0004982 | abnormal osteoclast morphology |
Cebpbtm2.1Acle |
Cebpbtm2.1Acle/Cebpbtm2.1Acle | involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 | color key |
MP:0001541 | abnormal osteoclast physiology |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0001541 | abnormal osteoclast physiology |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0002439 | abnormal plasma cell morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0005508 | abnormal skeleton morphology |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0002356 | abnormal spleen red pulp morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0008472 | abnormal spleen secondary B follicle morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002357 | abnormal spleen white pulp morphology |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0001134 | absent corpus luteum |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0009009 | absent estrous cycle |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0003199 | calcified muscle |
Cebpbtm3Nerl |
Cebpbtm3Nerl/Cebpbtm3Nerl | either: B6.129P2-Cebpb or (involves: 129P2/OlaHsd * C57BL/6) | color key |
MP:0006043 | decreased apoptosis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | FVB.129S-Cebpb | color key |
MP:0010869 | decreased bone trabecula number |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0010876 | decreased bone volume |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0000352 | decreased cell proliferation |
Cebpbtm2.1Acle |
Cebpbtm2.1Acle/Cebpbtm2.1Acle | involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 | color key |
MP:0002702 | decreased circulating free fatty acid level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002727 | decreased circulating insulin level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0008618 | decreased circulating interleukin-12 level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0005668 | decreased circulating leptin level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002644 | decreased circulating triglyceride level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002715 | decreased glycogen catabolism rate |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0009283 | decreased gonadal fat pad weight |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0004502 | decreased incidence of chemically-induced tumors |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | B6.Cg-Cebpb | color key |
MP:0002053 | decreased incidence of induced tumors |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | B6.Cg-Cebpb | color key |
MP:0005517 | decreased liver regeneration |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0005517 | decreased liver regeneration |
Cebpbtm2.1Acle |
Cebpbtm2.1Acle/Cebpbtm2.1Acle | involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 | color key |
MP:0004985 | decreased osteoclast cell number |
Cebpbtm2.1Acle |
Cebpbtm2.1Acle/Cebpbtm2.1Acle | involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 | color key |
MP:0003355 | decreased ovulation rate |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0005459 | decreased percent body fat |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0009400 | decreased skeletal muscle fiber size |
Cebpbtm3Nerl |
Cebpbtm3Nerl/Cebpbtm3Nerl | either: B6.129P2-Cebpb or (involves: 129P2/OlaHsd * C57BL/6) | color key |
MP:0008734 | decreased susceptibility to endotoxin shock |
Cebpbtm1Aki |
Cebpbtm1Aki/Cebpbtm1Aki | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0005616 | decreased susceptibility to type IV hypersensitivity reaction |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0009346 | decreased trabecular bone thickness |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0009307 | decreased uterine fat pad weight |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0009631 | enlarged axillary lymph nodes |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0009623 | enlarged inguinal lymph nodes |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0000702 | enlarged lymph nodes |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0008466 | enlarged mesenteric lymph nodes |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0000691 | enlarged spleen |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002742 | enlarged submandibular lymph nodes |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0011353 | expanded mesangial matrix |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0000240 | extramedullary hematopoiesis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0001926 | female infertility |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0001926 | female infertility |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0001926 | female infertility |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0002743 | glomerulonephritis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0002500 | granulomatous inflammation |
Cebpbtm1Aki |
Cebpbtm1Aki/Cebpbtm1Aki | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0005639 | hemosiderosis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0000189 | hypoglycemia |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * C57BL/6 * MF1 | color key |
MP:0000189 | hypoglycemia |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0003357 | impaired granulosa cell differentiation |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0008033 | impaired lipolysis |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0003356 | impaired luteinization |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0001798 | impaired macrophage phagocytosis |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0001129 | impaired ovarian folliculogenesis |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0002493 | increased IgG level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0000321 | increased bone marrow cell number |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0004992 | increased bone resorption |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0004992 | increased bone resorption |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0010868 | increased bone trabecula number |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0010875 | increased bone volume |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0010875 | increased bone volume |
Cebpbtm2.1Acle |
Cebpbtm2.1Acle/Cebpbtm2.1Acle | involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 | color key |
MP:0001745 | increased circulating corticosterone level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0008596 | increased circulating interleukin-6 level |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0008596 | increased circulating interleukin-6 level |
Cebpbtm2.1Acle |
Cebpbtm2.1Acle/Cebpbtm2.1Acle | involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 | color key |
MP:0002891 | increased insulin sensitivity |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0008663 | increased interleukin-12 secretion |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0009580 | increased keratinocyte apoptosis |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | B6.Cg-Cebpb | color key |
MP:0008873 | increased physiological sensitivity to xenobiotic |
Cebpbtm3Nerl |
Cebpbtm3Nerl/Cebpbtm3Nerl | either: B6.129P2-Cebpb or (involves: 129P2/OlaHsd * C57BL/6) | color key |
MP:0002412 | increased susceptibility to bacterial infection |
Cebpbtm1Aki |
Cebpbtm1Aki/Cebpbtm1Aki | involves: 129P2/OlaHsd * C57BL/6 | color key |
MP:0002412 | increased susceptibility to bacterial infection |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0005399 | increased susceptibility to fungal infection |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0009347 | increased trabecular bone thickness |
Cebpbtm2.1Acle |
Cebpbtm2.1Acle/Cebpbtm2.1Acle | involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 | color key |
MP:0011427 | mesangial cell hyperplasia |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0004510 | myositis |
Cebpbtm3Nerl |
Cebpbtm3Nerl/Cebpbtm3Nerl | either: B6.129P2-Cebpb or (involves: 129P2/OlaHsd * C57BL/6) | color key |
MP:0002169 | no abnormal phenotype detected |
Cebpbtm3.1Acle |
Cebpbtm3.1Acle/Cebpbtm3.1Acle | involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 | color key |
MP:0011088 | partial neonatal lethality |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0011090 | partial perinatal lethality |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0011086 | partial postnatal lethality |
Cebpbtm1Kish |
Cebpbtm1Kish/Cebpbtm1Kish | involves: 129P2/OlaHsd | color key |
MP:0011086 | partial postnatal lethality |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0011101 | partial prenatal lethality |
Cebpbtm1.1Acle |
Cebpbtm1.1Acle/Cebpbtm1.1Acle | involves: 129P2/OlaHsd * BALB/c * C57BL/6 | color key |
MP:0011101 | partial prenatal lethality |
Cebpbtm1Pfj |
Cebpbtm1Pfj/Cebpbtm1Pfj | involves: 129S1/Sv * C57BL/6 | color key |
MP:0002083 | premature death |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0011294 | renal glomerulus hypertrophy |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |
MP:0009419 | skeletal muscle fibrosis |
Cebpbtm3Nerl |
Cebpbtm3Nerl/Cebpbtm3Nerl | either: B6.129P2-Cebpb or (involves: 129P2/OlaHsd * C57BL/6) | color key |
MP:0001212 | skin lesions |
Cebpbtm1Vpo |
Cebpbtm1Vpo/Cebpbtm1Vpo | involves: 129S/SvEv * MF1 | color key |